SubHero Banner
Text

Arazlo (tazarotene) – New drug approval

December 19, 2019 - Bausch Health announced the FDA approval of Arazlo (tazarotene) lotion, for the topical treatment of acne vulgaris in patients 9 years of age and older..

Download PDF